Search research articles
Contact Us
Filters
Showing results (461-470 of 549) with videos related to
Page
of 55
Sort By:
Oncotarget
|
September 8, 2016
Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis
Lukas Goertz, Stefan Werner Schneider, Anna Desch, et al.
Cell Death & Disease
|
October 9, 2019
ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12
Loreen Kloss, Claudia Dollt, Kai Schledzewski, et al.
Stem Cell Reports
|
April 11, 2017
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
Mathias Bernhardt, Daniel Novak, Yassen Assenov, et al.
Oncoimmunology
|
June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models
Mareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
The Journal of Clinical Investigation
|
July 3, 2004
Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors
Philipp Beckhove, Markus Feuerer, Mathias Dolenc, et al.
International Journal of Cancer
|
April 10, 2021
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor
Qian Sun, Daniel Novak, Laura Hüser, et al.
The American Journal of Pathology
|
November 14, 1997
Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion
A E Bielawska, J P Shapiro, L Jiang, et al.
Physical Review Letters
|
August 8, 2022
Approaching Ideal Visibility in Singlet-Triplet Qubit Operations Using Energy-Selective Tunneling-Based Hamiltonian Estimation
Jehyun Kim, Jonginn Yun, Wonjin Jang, et al.
Journal of Neurosurgery
|
June 21, 2001
Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study
S Constantini, A Kanner, A Friedman, et al.
Journal for Immunotherapy of Cancer
|
March 18, 2022
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
Rebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, et al.
Page
of 55
Search research articles
Search
Showing results (461-470 of 549) with videos related to
Sort By:
Page
of 55
Oncotarget
|
September 8, 2016
Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis
Lukas Goertz, Stefan Werner Schneider, Anna Desch, et al.
Cell Death & Disease
|
October 9, 2019
ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12
Loreen Kloss, Claudia Dollt, Kai Schledzewski, et al.
Stem Cell Reports
|
April 11, 2017
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
Mathias Bernhardt, Daniel Novak, Yassen Assenov, et al.
Oncoimmunology
|
June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models
Mareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
The Journal of Clinical Investigation
|
July 3, 2004
Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors
Philipp Beckhove, Markus Feuerer, Mathias Dolenc, et al.
International Journal of Cancer
|
April 10, 2021
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor
Qian Sun, Daniel Novak, Laura Hüser, et al.
The American Journal of Pathology
|
November 14, 1997
Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion
A E Bielawska, J P Shapiro, L Jiang, et al.
Physical Review Letters
|
August 8, 2022
Approaching Ideal Visibility in Singlet-Triplet Qubit Operations Using Energy-Selective Tunneling-Based Hamiltonian Estimation
Jehyun Kim, Jonginn Yun, Wonjin Jang, et al.
Journal of Neurosurgery
|
June 21, 2001
Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study
S Constantini, A Kanner, A Friedman, et al.
Journal for Immunotherapy of Cancer
|
March 18, 2022
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
Rebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, et al.
Page
of 55